Dirceu Bartolomeu Greco

Dirceu Bartolomeu Greco

Auto-generated profile, based on publicly available information

Dirceu Bartolomeu Greco

Universidade Federal de Minas Gerais

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Cadernos de Saude Publica
Verified
Journal Article
Open access
PDF file
RDRegina Paiva Daumas
Regina Paiva Daumas
GSGulnar Azevedo e Silva
Gulnar Azevedo e Silva
RTRenato Tasca
Renato Tasca
ILIuri da Costa Leite
Iuri da Costa Leite
PBPatrícia Brasil
Patrícia Brasil
GCGastão Wagner de Sousa Campos
Gastão Wagner de Sousa Campos
Possibilidades no enfrentamento da COVID-19 El papel de la

1 July 2007 in AIDS
Verified
Journal Article
Closed access
DGDirceu B Greco
Dirceu B Greco
MSMariangela Simão
Mariangela Simão
The Brazilian AIDS Programme success is recognized worldwide, due to its integrated approach of prevention, respect for human rights and to free of charge universal access to state of the art antiretrovirals. As of 2006, 180,000 people living with AIDS are on HAART with 17 drugs available, receiving medical and laboratory care through the public health system. Costs for ART drugs reached US$ 400 million in 2006 and will increase steeply if the current trends are maintained: uptake of approximately 20,000 new patients/year and the need for more expensive, patent-protected second and third line drugs. We discuss the strengths and weaknesses of the programme, budgetary pressures, the need for more intense preventive efforts, for boosting local production of new drugs, for more investment in research and development and the issue of voluntary and compulsory licensing. There are many hurdles in pursuing long-term sustainability, which depends on country driven initiatives and international collaboration and participation. We conclude that the Brazilian experience demonstrated the capability of a developing country to treat people with equity, independently of race, gender or economic power and that this equality "seed" has already spread to other countries. Internally this experience must be used to tackle other endemic diseases, such as leprosy, malaria, dengue and leishmania. The Brazilian political will has been proven but, once again, there will be the need for concerted action by civil society, researchers, health professionals, people living with HIV/AIDS and the government to convince the world that health needs should not be treated as commercial issues, and that progress in research and development must be shared throughout the world if we expect to survive as a civilization.

1 May 2012 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MOMarcela Orsini
Marcela Orsini
JCJoão R. Canela
João R. Canela
JDJ. Disch
J. Disch
FMF. Maciel
F. Maciel
DGDirceu Greco
Dirceu Greco
ARAna Rabello
Ana Rabello
This study aims at estimating the prevalence of Leishmania infection among HIV-infected patients through the use of non-invasive tests. The study was conducted in three Infectious Diseases Services in two large Brazilian cities, both endemic areas for visceral leishmaniasis. Three hundred and eighty-one asymptomatic patients were enrolled whose ages ranged from 19 to 58 years old; 63.5% were men; mean TCD4+ was 380 cells/μl; and mean viral load was 153800 copies/ml. All individuals were tested for Leishmania infection through: ELISA using crude Leishmania infantum (ELISA), ELISA using the recombinant K39 antigen (rK39), indirect fluorescent antibody test (IFAT) and PCR targeted to kDNA region. The tests' positivity were: 10.8% (ELISA), 3.9% (IFAT), 0.8% (rK39), 6.3% PCR and 20.2% (overall, at least one positive test), with no statistical correlation between positivity and clinical and laboratorial variables. Concordance among tests was low (Kappa <0.20). Prevalence of Leishmania asymptomatic infection was high in this population, reinforcing the need for attention in the evaluation of HIV patients from endemic areas. New efforts are needed to develop more specific and sensitive tests to diagnose Leishmania asymptomatic infection. Highly active antiretroviral therapy (HAART) seems to have a protective role against disease progression in co-infected individuals.

1 January 2023 in Cadernos de Saude Publica
Verified
Journal Article
Open access
MDMARIA INES COSTA DOURADO
MARIA INES COSTA DOURADO
LMLaio Magno
Laio Magno
DGDirceu Bartolomeu Greco
Dirceu Bartolomeu Greco
EZEliana Miura Zucchi
Eliana Miura Zucchi
DFDulce Ferraz
Dulce Ferraz
AGAlexandre Grangeiro
Alexandre Grangeiro
At the end of 2017, Brazil adopted HIV pre-exposure prophylaxis (PrEP) as part of a combination prevention strategy for the most at-risk populations. However, Brazil does not have specific guidelines for PrEP use among adolescents aged < 18 years. Therefore, researchers from different health disciplines conducted PrEP1519, the first PrEP demonstration cohort study, ongoing in three Brazilian cities - Salvador, Belo Horizonte, and São Paulo - among adolescent men who have sex with men and transgender women, aged 15-19 years. This study aims to evaluate the effectiveness of PrEP in real-world settings. Quantitative and qualitative methods were integrated to obtain data on PrEP acceptability, uptake, use, and adherence. Moreover, comprehensive services and friendly environments were implemented in the PrEP1519 clinics. This study aims to describe the collaborative efforts of interdisciplinary practices in the development of the PrEP1519 study. The articulation of researchers from different institutions and areas is challenging; but it also allows for a broader outlook on questions regarding the direction of the research, while enriching the decisions needed to be taken during the interactions and negotiations among the different individuals, including the youth team and participants. Furthermore, it reflects on the communication process between cultures and languages considering the trans-epistemic arena of knowledge production about HIV, sexually transmitted infections, PrEP, and other combination prevention strategies for adolescents.

1 April 2006 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
JOJacqueline Ferreira de Oliveira
Jacqueline Ferreira de Oliveira
DGDirceu Bartolomeu Greco
Dirceu Bartolomeu Greco
GOGuilherme Oliveira
Guilherme Oliveira
PCPaulo Pereira Christo
Paulo Pereira Christo
MGMark Drew Crosland Guimarães
Mark Drew Crosland Guimarães
RORodrigo Corrêa Oliveira
Rodrigo Corrêa Oliveira
To study characteristics of neurological disorders in HIV/AIDS patients and their relationship to highly active antiretroviral treatment, a cross-sectional study was conducted in an infectious disease public hospital in Belo Horizonte, Brazil, between February 1999 and March 2000. Of the 417 patients enrolled, neurological disease was observed in 194 (46.5%) and a new AIDS-defining neurological event developed in 23.7% of individuals. Toxoplasmosis (42.3%), cryptococcosis meningitis (12.9%) and tuberculosis (10.8%) were the most common causes of neurological complications. The majority (79.3%) of patients were on highly active antiretroviral treatment and these individuals using HAART showed higher CD4 cell counts (p = 0.014) and presented stable neurological disease (p= 0.0001), although no difference was found with respect to the profile of neurological complications. The neurological diseases continue to be a frequent complication of HIV/AIDS and infections are still its main causes in Brazil, even in the highly active antiretroviral treatment era.

1 December 2008 in Atherosclerosis
Verified
Journal Article
Closed access
MGMilena Maria Moreira Guimarães
Milena Maria Moreira Guimarães
DGDirceu Bartolomeu Greco
Dirceu Bartolomeu Greco
SFSônia Maria Figueiredo
Sônia Maria Figueiredo
RFRodrigo Bastos Fóscolo
Rodrigo Bastos Fóscolo
AOAntônio Ribeiro de Oliveira
Antônio Ribeiro de Oliveira
LMLucas José de Campos Machado
Lucas José de Campos Machado